PDS Biotechnology Corporation (PDSB) vs Sangamo Therapeutics, Inc. (SGMOQ)

PDS Biotechnology Corporation and Sangamo Therapeutics, Inc. are both Biotechnology companies. PDS Biotechnology Corporation and Sangamo Therapeutics, Inc. are of similar size ($44.2M and $41.9M). PDS Biotechnology Corporation has the higher net margin (0.00% vs −356.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, PDS Biotechnology Corporation leads on 8 and Sangamo Therapeutics, Inc. on 4.

Valuation

Metric PDSB SGMOQ Biotechnology median
P/E n/m n/m 7.88
P/S n/m 1.58 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 1.79 10.73
Earnings yield (80.00%) (271.43%) (28.84%)
Free cash flow yield (37.14%) (165.83%) (23.03%)

Profitability

Metric PDSB SGMOQ Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (357.55%) 0.00%
Net margin 0.00% (356.89%) 0.00%
Free cash flow margin 0.00% (261.76%) 0.00%
Return on equity (543.97%) 1,755.72% (57.72%)
Return on assets (136.65%) (168.79%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PDSB SGMOQ Biotechnology median
Revenue growth (TTM) — (45.80%) 5.64%
EPS growth (last fiscal year) 28.16% 10.20% —
Revenue growth, 5-year CAGR — (19.66%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PDSB SGMOQ Biotechnology median
Debt to equity (1.21) 0.00 0.00
Current ratio 0.57 0.70 4.73
Net debt to EBITDA 0.50 0.18 0.96

Dividend

Metric PDSB SGMOQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PDSB SGMOQ Biotechnology median
Market cap 44.21m 41.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack